Quarterly report pursuant to Section 13 or 15(d)

Significant Strategic Collaborations (Details Narrative)

v3.22.2
Significant Strategic Collaborations (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Rcognized revenue $ 416,710 $ 287,603 $ 805,703 $ 478,819  
Revenue 416,710 287,603 805,703 478,819  
Research and development expenses 2,077,499 524,550 3,178,898 1,154,279  
Prepaid Expense and Other Assets, Current 448,733   448,733   $ 479,399
Payments or costs 0   0    
Scripps Research [Member] | Scripps Agreement [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Research and development expenses     2,400,000    
Prepaid Expense and Other Assets, Current 0   0   $ 200,000
Collaborative Agreements [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Rcognized revenue     0 0  
Royalty Revenue [Member] | Takeda [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Revenue $ 400,000 $ 300,000 $ 800,000 $ 500,000